Life Sciences

The COVID-19 pandemic magnified the importance of digital advances as companies raced to meet the demand for new testing, vaccines, and treatments to combat the pandemic. However, with increased competition, a shifting regulatory landscape, and growing demands from patients and health care providers, life sciences companies face significant challenges and must find ways to differentiate themselves and remain competitive.

Explore Deloitte's collection of content surrounding biopharma industry trends with a focus on AI in biopharma.

This report is a reflection of the progress made on all the pre-requisites identified in our Securing trust in the global COVID-19 supply chain report.

Our report looks at the state of R&D returns biopharma companies, the impact of the pandemic and how it accelerated the adoption of digital solutions and impacted the IRR.

Explore our research and discover why an archetype-based approach to enable targeted market access strategies may be more useful.

In this piece, we explore how biotech companies can expand into Europe — a tough market to conquer but a too important and large playing field to omit. 

Digital transformation in pharma is at an inflection point. Explore our survey with 150 biopharma leaders to better understand their experience.

Discover stakeholder perspectives on advancing research through racially and ethnically diverse clinical trials.